Clinical Oncology

Papers
(The TQCC of Clinical Oncology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Survival Outcomes for p16-positive Oropharyngeal Squamous Cell Carcinoma Based on Human Papillomavirus Status80
Assessing the Tolerability of Adjuvant and Neoadjuvant Chemotherapy in the Treatment of Early and Locally Advanced Breast Cancer in the Elderly Population at a UK Tertiary Cancer Centre79
RCR Meetings47
RCR Meetings43
Vascular Interventions in Oncology42
Localised Synovial Sarcoma in Adolescents and Young Adults Versus Adults – Is There a Difference in Outcome?42
OncoFlash–Research Updates in a Flash! (December 2022)41
Instant Oncology: Impower13340
Dosimetry in the Prediction and Reduction of Acute Skin Toxicity from the Use of Brass Bolus in Postmastectomy Chest Wall Radiotherapy Treatment40
OncoFlash – Research Updates in a Flash! (June 2022)39
An educational initiative to develop radiotherapy-specific teaching following the introduction of the oncology common stem year33
Audit of cabozantinib outcomes for metastatic renal cell carcinoma at Norfolk and Norwich University Hospital33
The First Use of Stereotactic Ablative Body Radiotherapy (SABR) in Extra-cranial Non-lung Oligometastatic Disease: A Single Centre32
Contact X-ray brachytherapy (CXB) for early rectal cancer: A review of outcomes from a single UK centre32
Improving Palliative Radiotherapy Training: A Multi-professional, Combined Clinical and Training Improvement Project30
The Time has Come to Say Goodbye28
Ayrshire Men Diagnosed with Locally Advanced Prostate Cancer between 2012 and 2013; How do they do?28
Perspectives of Healthcare Professionals on the Management and Treatment of Advanced Ovarian Cancer in the UK: Results From the KNOW-OC Survey27
Switching to a Fixed-dose Combined Pertuzumab and Trastuzumab With Recombinant Human Hyaluronidase Subcutaneous Injection to Treat Human Epidermal Growth Factor Receptor 2-positive Breast Cancer in Re27
What can the Interventional Endoscopist Offer in the Management of Upper Gastrointestinal Malignancies?27
OncoFlash: Research Updates in a Flash!26
Current Management Practices for Endometrial Cancer (EC) in the UK: A National Healthcare Professional Survey (KNOW-EC)25
The “real” outcome of esophageal cancer in elderly.24
Surgical Treatments of Benign Prostatic Hyperplasia and Prostate Cancer Stereotactic Radiotherapy: Impact on Long-Term Genitourinary Toxicity23
Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer23
Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER)23
Comparative Analysis of Stereotactic Radiation Therapy and Conventional Radiation Therapy in Cancer Pain Control: A Systematic Review and Meta-Analysis23
Dose-Painting Proton Radiotherapy Guided by Functional MRI in Non-enhancing High-Grade Gliomas23
Digital Medicine in Men with Advanced Prostate Cancer – A Feasibility Study of Electronic Patient-reported Outcomes in Patients on Systemic Treatment23
Hypofractionated Radiation Therapy in Keratinocyte Carcinoma22
Exploiting Deep Learning to Enhance Tumour-conformed Delineation and Reduced Isotropic Margin in Radiotherapy: Updated ESTRO-EANO Guidelines21
Radiomics in Oncology and Radiology: Statistical Significance Versus Clinical Significance21
Clinical Relevance of Immunohistochemical Subtypes in Early-Stage, Lymph Node-negative Breast Cancer. Results of a Large Cohort Study20
Response Letter to Laurelli et al. Letter to the Editor Regarding Enhancing Telemedicine to Improve Global Radiotherapy Access19
RCR Meetings19
Novel Therapies in Triple-negative Breast Cancer: Can less be More?19
Dose accumulation for pelvic Stereotactic Ablative Radiotherapy (SABR) reirradiation. In regard to Slevin et al.19
OncoFlash—Research Updates in a Flash!19
RCR Meetings18
Instant Oncology: ENACT18
Development of MRI Prostate Cancer Hypoxia Detection Sequences on the MR Linac17
Magnetic Resonance Imaging-Guided Adaptive Brachytherapy for the Treatment of Cervical Cancer and its Impact on Clinical Outcome17
Natural Language Processing to Extract Head and Neck Cancer Data From Unstructured Electronic Health Records17
Health Economics and Cancer Care17
Clinical Usefulness of Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography for the Detection of Prostate Cancer Biochemical Recurrence after Primary Radiation Th17
Validation of a Fully Automated Hybrid Deep Learning Cardiac Substructure Segmentation Tool for Contouring and Dose Evaluation in Lung Cancer Radiotherapy17
Use of Radiomics Models in Preoperative Grading of Cerebral Gliomas and Comparison with Three-dimensional Arterial Spin Labelling17
High Dose Rate Brachytherapy for Inoperable Endometrial Cancer: a Case Series and Systematic Review of the Literature16
Is it time to move from the Unidimensional RECIST 1.1 Response Assessment Criteria to a Volumetric Evaluation in the Present Era of Image-based Oncology? An Evaluation in Locally Advanced Head Neck Ca16
The study to assess the shifts of target volume in relation to bladder & rectal filling in patients undergoing pelvic image guided radiotherapy in carcinoma cervix and endometrium in post-operativ16
A Retrospective Study of 291 Patients With Head and Neck Sarcomas: Treatment, Outcomes, and Prognostic Factors16
Retrospective Analysis of Adaptive Radiotherapy in Locally Advanced Lung Cancer15
Organ and Function Preservation in Gastrointestinal Malignancies15
Retrospective Analysis of Adaptive Radiotherapy in Locally Advanced Lung Cancer15
Review of Conventional and High Dose Rate Brain Radiation (FLASH): Neurobehavioural, Neurocognitive and Assessment Issues in Rodent Models15
Body Composition and Dose-limiting Toxicity in Colorectal Cancer Chemotherapy Treatment; a Systematic Review of the Literature. Could Muscle Mass be the New Body Surface Area in Chemotherapy Dosing?14
Brachytherapy for Organ and Function Preservation in Soft-Tissue Sarcomas in Adult and Paediatric Patients14
Deintensification of Radiotherapy Use in Treatment of Ductal Carcinoma In Situ in the Netherlands–A Nationwide Overview From 2008 Until 202214
Third Course of Radical Intent Conformal Radiation in Patients with Primary Brain Tumors14
Expanding Global Radiotherapy Access via Telemedicine14
OncoFlash - Research Updates in a Flash! (June 2025)14
A Randomised Clinical Feasibility Trial of a Breast Immobilisation Device: The SuPPORT 4 All Bra14
Volumetric modulated arc radiotherapy with concomitant chemotherapy for the anal squamous carcinoma: A Welsh experience13
Patient-Centred Digital Medicine13
Peer review during COVID-19: Is it possible?13
DICER1 mutations exhibits a distinctive immune characteristics with enhanced immune checkpoint inhibitor efficacy in uterine corpus endometrial carcinoma13
Is this the Start of a New Era in Medicine? Media Influences Practice and Research13
Daily Adaptive Radiotherapy Using the Varian ETHOS System to Improve Dose Distribution During Treatment to the Upper Abdomen13
Liquid Biopsy Follow Up for Oropharyngeal Squamous Cell Carcinoma After Curative-Intent Treatment13
RCR Meetings13
Interstitial Lung Disease Associated with Trastuzumab Deruxtecan in HER2+ Metastatic Breast Cancer: a Real-world Experience12
Brain Metastasis Growth Kinetics: A Novel Prognosticator for Stereotactic Radiotherapy12
What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist?12
Evaluation and implementation of acute oncology service referral criteria: an evidence-based interdepartmental approach in a tertiary hospital in London12
Pushing the Borders: One at a Time. Reply to C. Onal, A. Elmaliy, P. Hurmuz's Letter to Editor Re: Patterns of Failure After Prostate-Only Radiotherapy in High-Risk Prostate Cancer: Implications for R12
Audit of Molecular Mechanisms of Primary and Secondary Resistance to Various Generations of Tyrosine Kinase Inhibitors in Known Epidermal Growth Factor Receptor-Mutant Non-small Cell Lung Cancer Patie12
Image-guided brachytherapy for locally advanced cervical cancer: audit of practice at UHNM 2023 and re-audit 202412
A Retrospective Analysis of Treatment of Recurrent VTE Events in Metastatic Breast Cancer12
Palbociclib or Ribociclib with Aromatase Inhibitor in Post-menopausal Women with ER+/HER2– Advanced Breast Cancer? Real-world Overall Survival Evidence12
The Oncologist of the Future11
The National Referral Service for Proton Beam Therapy in England: a journey towards equitable access.11
Organ Preservation in Rectal Cancer: An Overview of the Dutch Perspective and Recent Developments11
The Impact of Dose Rate on the Tumor Microenvironment Using Flattening-filter-free Beams11
Impact of the COVID-19 Outbreak on Cancer Staging in Brazil11
Identifying patient variables predisposing greater bowel gas variation in paediatric abdominal radiotherapy10
Single-Fraction Stereotactic Ablative Body Radiotherapy for Primary and Extracranial Oligometastatic Cancers10
Filler advert SCIENCEDIRECT_210x280.Pdf10
Neoadjuvant stereotactic ablative body radiotherapy for renal cell carcinoma with thrombus: do, or do not?10
Toxicity and Healthcare Utilisation of Dose-dense Chemotherapy for Early Breast Cancer10
Prophylactic Gastrostomy Placement in Head/Neck Patients at Clatterbridge (CCC): Review of Practice Against New Local Guidelines10
Differential Response of Pelvic Bone Marrow Fluorodeoxyglucose Uptake in Patients Receiving Concurrent Chemoradiotherapy10
Exploring gene expression in localised prostate cancer: Insights from a randomised control trial with a focus on hypoxia and angiogenic genomic biomarkers post-EBRT and HDR-BTb10
On Target 2: Updated Guidance for Image-guided Radiotherapy10
Overcoming Osimertinib Resistance in Advanced Non-small Cell Lung Cancer10
Component Patterns and Survival Outcomes in Patients with Mixed Malignant Ovarian Germ Cell Tumors: A Retrospective Cohort Study10
A National Referral Service for Paediatric Brachytherapy: An Evolving Practice and Outcomes Over 13 Years10
Preparing Breast Cancer Patients for Radiotherapy Treatment in the COVID-19 Era10
Online Adaptive Magnetic Resonance-guided Radiation Therapy for Gynaecological Cancers: Preliminary Results of Feasibility and Outcome10
Dosimetric Predictor of Acute and Late Gastrointestinal Toxicity Following Pelvic Chemoradiotherapy: A Prospective Single Institutional Study from Eastern India.9
Extra-mandibular Osteoradionecrosis after the Treatment of Head and Neck Cancer9
Target Volume Coverage and Organ at Risk Doses for Left-sided Whole-breast Irradiation With or Without Internal Mammary Chain Irradiation: A Comparison Between Three Techniques Representing the Past a9
Prospective analysis of patient reported outcomes following rectal spacer insertion prior to Prostate radiotherapy9
Letter to the Editor on an Original Research Article, Post-irradiation Dysbiosis in Patients With Nasopharyngeal Carcinoma Having Received Radiotherapy–A Pilot Study9
Role of radiation in oligo-progression in EGFR mutated metastatic non small cell lung cancer9
Feasibility and outcomes of craniospinal irradiation and concurrent daily carboplatin in children and adults with high-risk CNS tumours9
Patterns of Regional Failure after Pancreaticoduodenectomy in Patients with Distal Extrahepatic Cholangiocarcinoma: Suggestion of the Clinical Target Volume for Elective Nodal Irradiation9
Radiomics for Predicting Lung Cancer Outcomes Following Radiotherapy: A Systematic Review9
Effectiveness of Barrier Films in preventing radiation dermatitis severity in adjuvant hypofractionated whole breast irradiation with simultaneous integrated boost - An intrapatient randomised control9
Evaluating the feasibility of offline imaging in head and neck cancer patients treated with Halcyon E :- A Retrospective analysis of a large number of daily imaging based corrections .9
Real-world Safety of Bevacizumab with First-line Combination Chemotherapy in Patients with Metastatic Colorectal Cancer: Population-based Retrospective Cohort Studies in Three Canadian Provinces9
RADICALS-HD: Reflections before the Results are Known9
The National Radiotherapy Trials Quality Assurance Group – Driving up Quality in Clinical Research and Clinical Care9
Online Oncology Careers Events to Attract the Future Oncology Medical Workforce: An Exemplar Event and Review of the Literature8
Prehabilitation Reduces Hospital Admissions for Patients With Advanced Lung Cancer8
Survival Outcomes Following Concomitant Chemoradiation (CRT) for Stage III Non-small Cell Lung Cancer (NSCLC) at Oxford University8
Remote Consultations (RCs): a Survey of Oncology Practices and Patient Experience8
Impact of the COVID-19 Pandemic in Treating Breast Cancer (BC) Patients Receiving Systemic Anti-cancer Treatment (SACT): The Guy's Cancer Centre Experience8
Asking the right questions: Developing a peer-led practice question bank for the first FRCR8
Drug Appraisal Recommendations in Urological Oncology and Impact on Cancer Treatment Unit Visits at Sussex Cancer Network – 10-year Update8
The Clinicopathological Characteristics of POLE-mutated Colorectal Cancer and the Prognostic Value of POLE Status8
RCR Meetings8
OncoFlash - Research Updates in a Flash! (November edition)8
Yesterday, Today and Tomorrow – Are We Any Closer to Knowing Which Patients Will Benefit from Adjuvant Internal Mammary Nodal Irradiation?8
Efficacy and Safety of Preoperative Transcatheter Rectal Arterial Chemoembolisation in Patients with Locally Advanced Rectal Cancer: Results from a Prospective, Phase II PCAR Trial8
Accelerated Hypofractionated Radiotherapy for Centrally Located Lung Tumours Not Suitable for Stereotactic Body Radiotherapy or Chemoradiotherapy8
Unveiling Disparities: Exploring Differential Attainment in Postgraduate Training Within Clinical Oncology8
RCR Meetings8
Cardiac Stereotactic Ablative Radiotherapy – a Multidisciplinary Approach8
Effect of Primary Site and Treatment Modality of Patients With Head and Neck Myoepithelial Carcinoma on Survival7
Translation of Prognostic and Pharmacodynamic Biomarkers from Trial to Non-trial Patients with Metastatic Castration-resistant Prostate Cancer Treated with Docetaxel7
The Changing Landscape for the Treatment of Painful Spinal Metastases: is Stereotactic Body Radiation Therapy the New Standard of Care?7
Correspondence to the Editor: Reirradiation in Paediatric Tumors of the Central Nervous System: Outcome and Side Effects After Implementing National Guidelines7
Contralateral Nodal Relapse in Well-lateralised Oral Cavity Cancers Treated Uniformly with Ipsilateral Surgery and Adjuvant Radiotherapy With or Without Concurrent Chemotherapy: a Retrospective Study7
Regarding "Neuroendocrine Deficits and Weight Development Before and After Proton Therapy in Children With Craniopharyngioma" by Bischoff et al.7
Clinical Predictors of Response to Anti-PD-1 First-Line Treatment in a Single-Centre Patient Cohort: A Real-World Study7
A sub-study to assess the agreement between the anti-cancer treatment records in Systemic Anticancer Therapy (SACT) and Hospital Episode Statistics (HES) database from a large-scale retrospective coho7
What is the Optimal Dose, Fractionation and Volume for Bladder Radiotherapy?7
Integration of genomic testing into biliary tract cancer management and creation of a standard East Midlands treatment algorithm: a retrospective analysis of clinical outcomes and molecular profiling 7
Outcomes of Patients Treated in the UK Proton Overseas Programme: Central Nervous System Group7
Contact X-Ray Brachytherapy for Early Rectal Cancer: A Review of Outcomes From a Single UK Centre7
A review of factors contributing to failure of deep inspiration breath hold in left breast radiotherapy7
Federated Learning Survival Model and Potential Radiotherapy Decision Support Impact Assessment for Non–small Cell Lung Cancer Using Real-World Data7
Long-term Results of Hypofractionated Radiotherapy With Intra-prostatic Boosts in Men With Intermediate- and High-risk Prostate Cancer: A Phase II Trial7
A Novel Model and Infrastructure for Clinical Outcomes Data Collection and Their Systematic Evaluation for UK Patients Receiving Proton Beam Therapy7
Innovative Follow-up Strategies for Endometrial Cancer7
Early Outcomes of Preoperative Short Course Radiotherapy With Simultaneous Integrated Boost and Response-adapted Chemotherapy for Advanced Rectal Cancer7
Comparing the Robustness of Intensity-modulated Proton Therapy and Proton-arc Therapy Against Interplay Effects of 4D Robust-optimised Plans for Lung Stereotactic Body Radiotherapy7
An Overview of the Role of Radiotherapy in the Treatment of Small Cell Lung Cancer – A Mainstay of Treatment or a Modality in Decline?7
Technical Aspects of a National Service for Paediatric Pelvic Brachytherapy7
Hypoxia and its Modification in Bladder Cancer: Current and Future Perspectives7
Structural Quality Indicators in Radiation Oncology: Insights and Implications7
The STAMPEDE2 Trial: a Site Survey of Current Patterns of Care, Access to Imaging and Treatment of Metastatic Prostate Cancer6
Early Real-world Safety Data of Darolutamide in Non-metastatic Castrate-resistant Prostate Cancer6
Real-world Outcomes of Adjuvant Carboplatin in Stage 1 Seminoma6
Reading the Mind of a Machine: Hopes and Hypes of Artificial Intelligence for Clinical Oncology Imaging6
A Nomogram for Predicting Progression-free Survival in Patients with Endometrial Cancer6
Commentary on the New National Institute for Health and Care Excellence Guideline for Metastatic Spinal Cord Compression6
Reflection on Black and Ethnic Minority Participation in Clinical Trials6
Palliative Radiotherapy for Haemostasis in Malignancy: a Systematic Review6
A Multicentre Clinical Study of Sarcoma Personalised Treatment Using Patient-Derived Tumour Xenografts6
Stereotactic Body Radiation Therapy for Pulmonary Metastasis from Colorectal Adenocarcinoma: Biologically Effective Dose 150 Gy is Preferred for Tumour Control6
Beyond Teenage and Young Adult Cancer Care: Care Experiences of Patients Aged 25–39 Years Old in the UK National Health Service6
Now is Our Opportunity to Revolutionise Cancer Clinical Trials6
Registries, Databases and Repositories for Developing Artificial Intelligence in Cancer Care6
Rates of Neutropenia following the Introduction of G-CSF to Upfront Docetaxel6
Lacrimal Carcinoma Ex Pleomorphic Adenoma: A Population-based Study6
Surveillance and Deregulated Pathways in Oral Merkel Cell Carcinoma6
Counterpoint: Does Mastectomy Reduce Overall Survival in Early Stage Breast Cancer?6
NOTCH and BONUS as Vehicles for Early and Sustained Leadership Training6
Can Quantitative Measures of T790M Allelic Fraction Predict Survival Outcomes in Patients Receiving Osimertinib? Observations From an Early Access Programme6
Does expanded access to primary prophylaxis with G-CSF decrease the burden of febrile neutropenia?5
Correspondence to the Editor: Assessing a Suitable Radiotherapy Utilisation Benchmark for Older Patients With Head and Neck Cancer5
PD-1/PD-L1 Inhibitors in Combination With Chemo or as Monotherapy vs. Chemotherapy Alone in Advanced, Unresectable HER2-Negative Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Me5
The Management of Oligometastases in Non-small Cell Lung Cancer – is Stereotactic Ablative Radiotherapy now Standard of Care?5
Patient-Reported Outcomes and Health-Related Quality of Life Following Radiotherapy for Bladder Cancer5
Stereotactic Ablative Radiotherapy for Oligometastatic Disease: A Tale of Emperor's New Clothes or New Standard of Care?5
3D conformal versus IMRT for early-stage squamous cell carcinoma of larynx5
Radiotherapy Quality Assurance in the PORTEC-3 (TROG 08.04) Trial5
The Importance of Tackling the Social Determinants of Health to Address the Unmet Need within Cancer Services. Reflections from Build Back Fairer: the COVID-19 Marmot Review5
Reductions of pelvic nodal planning target volume margins in cervix radiotherapy to improve bowel dose constraints5
First Clinical Experience And Clinical Results Using A New Non- Coplanar- Mono Isocentric Technique (HyperArc) For Linac Based Vmat Radiosurgery In Brain Metastases5
The COVID-19 Pandemic – A Cause for Late Presentation of Sarcoma Patients?5
Implementation of a drive-through/courier service for collecting oral anti-cancer medicines in response to the COVID-19 pandemic5
HERMES: Delivery of a Speedy Prostate Cancer Treatment5
Single-centre Experience Comparing PBI to WBRT and the Effects on Volume of Breast Tissue Treated, Heart and Lung Dosimetry5
Quality of Decision Making in Radiation Oncology5
Changes in the Management of Patients having Radical Radiotherapy for Lung Cancer during the First Wave of the COVID-19 Pandemic in the UK5
Salvage Radiotherapy in Localised Prostate Cancer Patients over a 4-year Follow-up Period: Single Centre Analysis5
A Sussex-wide Immunotherapy Toxicity Service to Optimise Patient Care and Redistribute Workload from Tumour-specific Oncologists5
3D Conformal Radiotherapy versus Volumetric Modulated Arc Therapy in the Treatment of the Internal Mammary Chain and Supraclavicular Fossa in Adjuvant Breast Radiotherapy5
Assessment of Quality of Life in Rectal Cancer with Organ-Preservation Treatment: Are We There yet?5
The Effect of Breast Cancer Subtype on Symptom Improvement Following Palliative Radiotherapy for Bone Metastases5
Standardising Clinic Letters to Aid Care Beyond the Cancer Centre5
Audit of Neoadjuvant Chemoradiotherapy Outcomes for Locally Advanced Oesophageal Cancer at Oxford University Hospital Trust5
Image-guided Adaptive Radiotherapy for Bladder Cancer5
Guidelines on the Use of Systemic Therapy in Patients with Advanced Thyroid Cancer5
What is so Special About Digital Health in Cancer?5
RCR Meetings5
Image-guided Interstitial Brachytherapy in the Treatment of Primary and Recurrent Vulvovaginal Gynaecological Malignancies5
A Retrospective Evaluation of Clinical Outcomes of Patients Undergoing Cystectomy for Bladder Cancer at a Specialist Centre; Real-world Data from University College London Hospital5
Decision Regret among Patients with Early-stage Lung Cancer Undergoing Radiation Therapy or Surgical Resection5
What Can Proton Beam Therapy Achieve for Patients with Pectus Excavatum Requiring Left Breast, Axilla and Internal Mammary Nodal Radiotherapy?5
Therapeutic Outcome of Stereotactic Body Radiotherapy for Small Hepatocellular Carcinoma Lesions – A Systematic Review and Network Meta-analysis5
Change in the Use of Fractionation in Radiotherapy Used for Early Breast Cancer at the Start of the COVID-19 Pandemic: A Population-Based Cohort Study of Older Women in England and Wales5
Letter to the Editor Regarding: Stereotactic Radiosurgery With Volumetric Modulated Arc Radiotherapy: Final Results of a Multi-arm Phase I Trial (DESTROY-2)5
Regarding ‘Impact of the COVID-19 Outbreak on Cancer Staging in Brazil’: Navigating the Impact of the Pandemic on Neuro-Oncology Procedures4
Response adapted de-escalation of neo-adjuvant therapy for intermediate risk HER2-positive early breast cancer: an institutional experience4
National Institute for Health and Care Excellence and Royal College of Radiologists' Fractionation Guideline for Metastatic Spinal Cord Compression4
Foreword4
DNA Repair Genetics and the Risk of Radiation Pneumonitis in Patients With Lung Cancer: A Systematic Review and Meta-analysis4
Rationale and Design of a Phase II Trial of Combined Serplulimab and Chemotherapy in Patients with Histologically Transformed Small Cell Lung Cancer: a Prospective, Single-arm and Multicentre Study4
Decline in Cancer Diagnoses during the ‘Zero COVID’ Policy in Hong Kong: Indirect Spillover Impact of the COVID-19 Pandemic4
Improving the experience of returning to clinical oncology training through an educational day for out-of-programme trainees4
BONUS: the National Oncology Network for Students and Junior Doctors4
Reirradiation in Paediatric Tumours of the Central Nervous System: Outcome and Side Effects After Implementing National Guidelines4
Reirradiation for head and neck cancer: a single-centre experience4
In Response to: ‘Should We be Offering our Patients with Oligometastases Stereotactic Ablative Body Radiotherapy?’ by Ostler et al. and ‘Should We be Offering our Patients with Oligometastases Stereot4
Socioeconomic Deprivation Correlates With Incomplete Radiotherapy Treatment in Head and Neck Cancer4
Patterns of Response to Treatment and Further Treatment on Progression in Patients Receiving CDK4/6 Inhibitors (CDK4/6i) for ER+ve, HER2-ve Metastatic Breast Cancer (MBC)4
Irradiation of the Internal Mammary Chain in the Adjuvant Treatment of Breast Cancer – a Retrospective, Single Institution Review of Outcomes4
Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015–20234
Real world experience of online adaptive radiotherapy for treatment of muscle invasive bladder cancer4
Advances in External Beam Radiation Therapy and Brachytherapy for Cervical Cancer4
RCR Meetings4
Developing UK Guidance on How Long Men Should Abstain from Receiving Anal Sex before, During and after Interventions for Prostate Cancer4
Long-Term Biochemical Control of a Prospective Cohort of Prostate Cancer Patients Treated With Interstitial Brachytherapy Versus Radical Prostatectomy4
Artificial Intelligence for Radiation Treatment Planning: Bridging Gaps From Retrospective Promise to Clinical Reality4
Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease4
Improving the palliative radiotherapy training experience of junior clinical oncology trainees4
A Systematic Review of Deep Inspiration Breath Hold and Free Breathing in Proton Beam Therapy Plans for Breast Cancer Radiotherapy4
Letter to the Editor Regarding the Article “PTV Margins in MR-guided and Beam-gated SBRT of Liver Metastases: GTV Dose Escalation Can Reduce the Required PTV”4
Potential for Isotoxic Re-irradiation Stereotactic Ablative Body Radiotherapy in Locally Recurrent Rectal Cancer4
Immunotherapy and Systemic Therapy in Metastatic/Recurrent Endometrial and Cervical Cancers4
Enhancement and Size-based Response Criteria for Evaluating Tyrosine Kinase Inhibitor Dosing Strategy in Metastatic Renal Cancer: Prospective Imaging Study from the UK STAR Trial4
The National Cancer Research Institute Clinical and Translational Radiotherapy Research Working Group Workshop: Translating Novel Discoveries to and from the Clinic4
Confirmation of Improvement in Target Dose Dosimetry for Image-guided Adaptive Brachytherapy in Cervical Cancer4
Virtual follow-up after prostate radiotherapy: A successful model utilising non-clinical personnel to streamline care and optimise patient outcomes4
Impact of postcode on treatment for metastatic hormone-sensitive prostate cancer: May the odds be ever in your favour4
OncoFlash – Research Updates in a Flash! (August 2022)4
Is the Criteria for Direct Access to CT Scans in Primary Care for Suspected Pancreatic Cancer Being Met?4
The Role of Contact X-Ray Brachytherapy in Early Rectal Cancer – Who, when and How?4
The Long and the Short of it: the Role of Short-course Radiotherapy in the Neoadjuvant Management of Rectal Cancer4
Another Brick in the Wall … no More! Breaking the Sex Bias4
Global Research on the Treatment of Cancer Patients During the COVID-19 Pandemic: Visualisation and Bibliometric Analysis4
Imaging of Neck Nodes in Head and Neck Cancers – a Comprehensive Update4
Oncoflash – Research Updates in a Flash!4
Time to Rethink Commercialisation: Spin out or Lose out?4
RCR Meetings4
Adopting Machine Learning Auto-Segmentation Into Radiotherapy Workflow4
RCR Meetings4
0.31094694137573